Nordea Equity Research upgraded shares of Demant A/S (OTCMKTS:WILYY – Free Report) from a hold rating to a buy rating in a research report released on Tuesday, FlyOnTheWall reports.
Several other research analysts have also issued reports on WILYY. Handelsbanken lowered Demant A/S from an outperform rating to a market perform rating in a research report on Monday, May 8th. Sanford C. Bernstein started coverage on Demant A/S in a research report on Friday, May 12th. They issued an outperform rating for the company. Three analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of Hold and a consensus target price of $210.75.
Check Out Our Latest Stock Analysis on Demant A/S
Demant A/S Price Performance
About Demant A/S
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Read More
- Five stocks we like better than Demant A/S
- What is an Earnings Surprise?
- AI is Turning Things Up for Upwork
- Stock Market Sectors: What Are They and How Many Are There?
- 2 Tech Stocks to Buy and One to Avoid in August
- How to Invest in E-Commerce: A Guide
- 5 Best Fintech Stocks to Buy Now
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.